• 1
    Khan KS, Wojdyla D, Say L, Gulmezoglu AM, van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006;367:106674.
  • 2
    Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol 2011;25:391403.
  • 3
    Dahlstrom BL, Engh ME, Bukholm G, Oian P. Changes in the prevalence of pre-eclampsia in Akershus county and the rest of Norway during the past 35 years. Acta Obstet Gynecol Scand 2006;85:91621.
  • 4
    Wallis AB, Saftlas AF, Hsia J, Atrash HK. Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987–2004. Am J Hypertens 2008;21:5216.
  • 5
    Bowyer L. The confidential enquiry into maternal and child health (CEMACH). Saving mothers’ lives: reviewing maternal deaths to make motherhood safer 2003–2005. The Seventh Report on confidential enquiries into maternal deaths in the UK. In: Lewis G (Ed.) London: CEMACH, 2007.
  • 6
    Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta 2009;30 (Suppl A):S327.
  • 7
    Than NG, Romero R, Meiri H, Erez O, Xu Y, Tarquini F, et al. PP13, maternal ABO blood groups and the risk assessment of pregnancy complications. PLoS One 2011;6:e21564.
  • 8
    Hiltunen LM, Laivuori H, Rautanen A, Kaaja R, Kere J, Krusius T, et al. Blood group AB and factor V Leiden as risk factors for pre-eclampsia: a population-based nested case–control study. Thromb Res 2009;124:16773.
  • 9
    Spinillo A, Capuzzo E, Baltaro F, Piazzi G, Iasci A. Case–control study of maternal blood group and severe pre-eclampsia. J Hum Hypertens 1995;9:6235.
  • 10
    Clark P, Wu O. ABO(H) blood groups and pre-eclampsia a systematic review and meta-analysis. Thromb Haemost 2008;100:46974.
  • 11
    Motavkina NS, Avelichev ON. [Structure of the late toxicosis of pregnancy depending on the blood groups of the ABO system]. Akush ginekol (Mosk) 1974;3:678.
  • 12
    Lee BK, Ploner A, Zhang Z, Gryfelt G, Wikman A, Reilly M. Constructing a population-based research database from routine maternal screening records: a resource for studying alloimmunization in pregnant women. PLoS One 2011;6:e27619.
  • 13
    Edgren G, Hjalgrim H, Rostgaard K, Norda R, Wikman A, Melbye M, et al. Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study. Am J Epidemiol 2010;172:12805.
  • 14
    Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, et al. External review and validation of the Swedish national inpatient register. BMC Public Health 2011;11:450.
  • 15
    Ros HS, Cnattingius S, Lipworth L. Comparison of risk factors for preeclampsia and gestational hypertension in a population-based cohort study. Am J Epidemiol 1998;147:106270.
  • 16
    Campbell DM, MacGillivray I. Preeclampsia in twin pregnancies: incidence and outcome. Hypertens Pregnancy 1999;18:197207.
  • 17
    Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet 2010;376:63144.
  • 18
    Campbell DM, MacGillivray I, Carr-Hill R. Pre-eclampsia in second pregnancy. Br J Obstet Gynaecol 1985;92:13140.
  • 19
    Wiggins KL, Smith NL, Glazer NL, Rosendaal FR, Heckbert SR, Psaty BM, et al. ABO genotype and risk of thrombotic events and hemorrhagic stroke. J Thromb Haemost 2009;7:2639.
  • 20
    Blann AD, Daly RJ, Amiral J. The influence of age, gender and ABO blood group on soluble endothelial cell markers and adhesion molecules. Br J Haematol 1996;92:498500.
  • 21
    Qi L, Cornelis MC, Kraft P, Jensen M, van Dam RM, Sun Q, et al. Genetic variants in ABO blood group region, plasma soluble E-selectin levels and risk of type 2 diabetes. Hum Mol Genet 2010;19:185662.
  • 22
    Thadhani R, Stampfer MJ, Hunter DJ, Manson JE, Solomon CG, Curhan GC. High body mass index and hypercholesterolemia: risk of hypertensive disorders of pregnancy. Obstet Gynecol 1999;94:54350.
  • 23
    Paterson AD, Lopes-Virella MF, Waggott D, Boright AP, Hosseini SM, Carter RE, et al. Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin. Arterioscler Thromb Vasc Biol 2009;29:195867.
  • 24
    Barbalic M, Dupuis J, Dehghan A, Bis JC, Hoogeveen RC, Schnabel RB, et al. Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. Hum Mol Genet 2010;19:186372.
  • 25
    Meigs JB, Hu FB, Rifai N, Manson JE. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 2004;291:197886.
  • 26
    Nadar S, Blann AD, Lip GY. Endothelial dysfunction: methods of assessment and application to hypertension. Curr Pharm Des 2004;10:3591605.
  • 27
    Carty DM, Anderson LA, Freeman DJ, Welsh PI, Brennand JE, Dominiczak AF, et al. Early pregnancy soluble E-selectin concentrations and risk of preeclampsia. J Hypertens 2012;30:9549.
  • 28
    Erez O, Romero R, Espinoza J, Fu W, Todem D, Kusanovic JP, et al. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. J Matern Fetal Neonatal Med 2008;21:27987.
  • 29
    Chedraui P, Lockwood CJ, Schatz F, Buchwalder LF, Schwager G, Guerrero C, et al. Increased plasma soluble fms-like tyrosine kinase 1 and endoglin levels in pregnancies complicated with preeclampsia. J Matern Fetal Neonatal Med 2009;22:56570.
  • 30
    Lorquet S, Pequeux C, Munaut C, Foidart JM. Aetiology and physiopathology of preeclampsia and related forms. Acta Clin Belg 2010;65:23741.